Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tilanus

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Human Immunology|August 10, 1999
Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomasM Feenstra, E Rozemuller, K Duran, et al.
Tissue Antigens|October 16, 1999
HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomasM Feenstra, M Veltkamp, J van Kuik, et al.
Tissue Antigens|July 8, 2000
Criteria to define HLA haplotype loss in human solid tumorsL M Ramal, M Feenstra, A W van der Zwan, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 4, 1995
[Initial Dutch results with a presymptomatic DNA tests in familial breast/ovarian carcinoma. Rotterdamse Werkgroep voor Erfelijke Tumoren]J G Klijn, P Devilee, A N van Geel, et al.
Journal of Neuromuscular Diseases|September 4, 2018
Respiratory Assessment of ALS Patients: A Nationwide Survey of Current Dutch PracticeT B M Tilanus, J T Groothuis, J M C Ten Broek-Pastoor, et al.
Journal of Neuromuscular Diseases|October 30, 2018
Respiratory Assessment of ALS Patients: A Nationwide Survey of Current Dutch PracticeT B M Tilanus, J T Groothuis, J M C Ten Broek-Pastoor, et al.
Tissue Antigens|November 20, 1998
Description of a new DRB1*11 allele (DRB1*1132)P Loiseau, M N Loste, V Lepage, et al.
Clinical Biochemistry|January 6, 2009
MUC1 568 A/G genotype-dependent cancer antigen 15-3 levels in breast cancer patientsAdrian Kruit, Madeleine M Tilanus-Linthorst, Joke G Boonstra, et al.
American Journal of Human Genetics|February 1, 1993
Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspectsR C Hennekam, M Tilanus, B C Hamel, et al.
Disease Markers|December 14, 1999
Breast cancer screening in high-risk women. Rotterdam Committee of Medical and Genetic CounselingC T Brekelmans, C C Bartels, E Crepin, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Human Immunology|August 10, 1999
Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomasM Feenstra, E Rozemuller, K Duran, et al.
Tissue Antigens|October 16, 1999
HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomasM Feenstra, M Veltkamp, J van Kuik, et al.
Tissue Antigens|July 8, 2000
Criteria to define HLA haplotype loss in human solid tumorsL M Ramal, M Feenstra, A W van der Zwan, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 4, 1995
[Initial Dutch results with a presymptomatic DNA tests in familial breast/ovarian carcinoma. Rotterdamse Werkgroep voor Erfelijke Tumoren]J G Klijn, P Devilee, A N van Geel, et al.
Journal of Neuromuscular Diseases|September 4, 2018
Respiratory Assessment of ALS Patients: A Nationwide Survey of Current Dutch PracticeT B M Tilanus, J T Groothuis, J M C Ten Broek-Pastoor, et al.
Journal of Neuromuscular Diseases|October 30, 2018
Respiratory Assessment of ALS Patients: A Nationwide Survey of Current Dutch PracticeT B M Tilanus, J T Groothuis, J M C Ten Broek-Pastoor, et al.
Tissue Antigens|November 20, 1998
Description of a new DRB1*11 allele (DRB1*1132)P Loiseau, M N Loste, V Lepage, et al.
Clinical Biochemistry|January 6, 2009
MUC1 568 A/G genotype-dependent cancer antigen 15-3 levels in breast cancer patientsAdrian Kruit, Madeleine M Tilanus-Linthorst, Joke G Boonstra, et al.
American Journal of Human Genetics|February 1, 1993
Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspectsR C Hennekam, M Tilanus, B C Hamel, et al.
Disease Markers|December 14, 1999
Breast cancer screening in high-risk women. Rotterdam Committee of Medical and Genetic CounselingC T Brekelmans, C C Bartels, E Crepin, et al.
Pageof 6